Zomedica Corporation launched its second equine-focused assay, Cortisol for equine serum, on its TRUFORMA diagnostic platform for in-clinic use by equine veterinarians.

Zomedica Corporation launched its second equine-focused assay, Cortisol for equine serum, on its TRUFORMA® diagnostic platform. This point-of-care device enables in-clinic and stall-side testing for equine veterinarians, allowing them to make real-time, potentially life-saving treatment decisions for sick foals. The TRUFORMA platform addresses a $1.5B annual recurring revenue opportunity in the US, with expansion into Europe anticipated.

June 27, 2024
3 Articles

Further Reading